• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同铱-192源模型对高剂量率近距离放射治疗剂量计算的影响。

Impact of different Ir-192 source models on dose calculations in high-dose-rate brachytherapy.

作者信息

Otani Yuki, Shimamoto Shigetoshi, Sumida Iori, Takahashi Yutaka, Tani Shoji, Oshima Tetsuya, Onosaka Satoshi, Isohashi Fumiaki, Tamari Keisuke, Ogawa Kazuhiko

机构信息

Department of Radiology, Kaizuka City Hospital, Japan.

Department of Radiation Oncology, Osaka University Graduate School of Medicine, Japan.

出版信息

Phys Imaging Radiat Oncol. 2018 Aug 31;7:23-26. doi: 10.1016/j.phro.2018.08.004. eCollection 2018 Jul.

DOI:10.1016/j.phro.2018.08.004
PMID:33458401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807939/
Abstract

In high-dose-rate brachytherapy, the geometry of the radioactive source is sometimes updated. Some institutions use a different source model for the dose calculation in treatment planning and treatment. The effects of this discrepancy were examined for four types of treatment plans, and ten patients were selected for each treatment plan. The impact of different source models depended on the types of treatment plan, patients, and dose index. To reduce the uncertainty and improve the reliability of the data, it would be better to use more robust metrics (D and D) for treatment planning evaluation in facilities with this problem.

摘要

在高剂量率近距离放射治疗中,放射源的几何形状有时会更新。一些机构在治疗计划和治疗的剂量计算中使用不同的源模型。针对四种治疗计划研究了这种差异的影响,每种治疗计划选取了10名患者。不同源模型的影响取决于治疗计划的类型、患者和剂量指数。为了减少不确定性并提高数据的可靠性,对于存在此问题的机构,在治疗计划评估中使用更稳健的指标(D和D)会更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73e6/7807939/d04d1397f8ab/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73e6/7807939/79a798959294/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73e6/7807939/d04d1397f8ab/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73e6/7807939/79a798959294/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73e6/7807939/d04d1397f8ab/fx1.jpg

相似文献

1
Impact of different Ir-192 source models on dose calculations in high-dose-rate brachytherapy.不同铱-192源模型对高剂量率近距离放射治疗剂量计算的影响。
Phys Imaging Radiat Oncol. 2018 Aug 31;7:23-26. doi: 10.1016/j.phro.2018.08.004. eCollection 2018 Jul.
2
Dosimetry modeling for focal high-dose-rate prostate brachytherapy.聚焦高剂量率前列腺近距离放射治疗的剂量测定建模
Brachytherapy. 2014 Nov-Dec;13(6):611-7. doi: 10.1016/j.brachy.2014.06.007. Epub 2014 Jul 29.
3
Dosimetric comparison of Co and Ir high dose rate source used in brachytherapy treatment of cervical cancer.用于宫颈癌近距离放射治疗的钴源和铱源高剂量率的剂量学比较。
J Cancer Res Ther. 2019 Oct-Dec;15(6):1212-1215. doi: 10.4103/jcrt.JCRT_372_19.
4
Rectal separation using hydroxypropyl methylcellulose in intracavitary brachytherapy of cervical cancer: an innovative approach.在宫颈癌腔内近距离放疗中使用羟丙基甲基纤维素进行直肠分离:一种创新方法。
J Contemp Brachytherapy. 2016 Oct;8(5):399-403. doi: 10.5114/jcb.2016.62951. Epub 2016 Oct 11.
5
A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.一种用于评估超越TG-43形式主义的基于模型剂量计算的通用高剂量率(192)铱近距离治疗源。
Med Phys. 2015 Jun;42(6):3048-61. doi: 10.1118/1.4921020.
6
Advanced dose calculation algorithm in superficial brachytherapy - the impact of tissue inhomogeneity on treatment plan dosimetry.浅表近距离放射治疗中的先进剂量计算算法——组织不均匀性对治疗计划剂量测定的影响。
J Contemp Brachytherapy. 2021 Aug;13(4):441-446. doi: 10.5114/jcb.2021.106541. Epub 2021 May 28.
7
Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.局部晚期宫颈癌患者中脉冲剂量率与高剂量率近距离放疗的放射生物学优化比较
Brachytherapy. 2019 May-Jun;18(3):370-377. doi: 10.1016/j.brachy.2018.12.009. Epub 2019 Feb 21.
8
A robust evaluation of 49 high-dose-rate prostate brachytherapy treatment plans including all major uncertainties.对包括所有主要不确定性在内的 49 例高剂量率前列腺近距离治疗计划进行了稳健评估。
J Appl Clin Med Phys. 2024 Feb;25(2):e14182. doi: 10.1002/acm2.14182. Epub 2023 Oct 14.
9
Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.用于旋转屏蔽近距离放射治疗的具有平滑度控制的非对称剂量体积优化。
Med Phys. 2014 Nov;41(11):111709. doi: 10.1118/1.4897617.
10
Comparison of TG-43 and TG-186 in breast irradiation using a low energy electronic brachytherapy source.使用低能电子近距离放射治疗源进行乳腺照射时TG-43与TG-186的比较。
Med Phys. 2014 Jun;41(6):061701. doi: 10.1118/1.4873319.

引用本文的文献

1
Reevaluating BED in cervical cancer HDR brachytherapy: source decay and tissue-specific repair significantly impact radiobiological dose.重新评估宫颈癌高剂量率近距离放疗中的BED:源衰减和组织特异性修复对放射生物学剂量有显著影响。
Front Oncol. 2025 May 5;15:1407606. doi: 10.3389/fonc.2025.1407606. eCollection 2025.
2
High dose rate 192Ir brachytherapy source model Monte Carlo dosimetry: mHDR-v2 and mHDR-v2r.高剂量率 192Ir 近距离治疗源模型蒙特卡罗剂量学:mHDR-v2 和 mHDR-v2r。
PLoS One. 2024 Feb 9;19(2):e0298550. doi: 10.1371/journal.pone.0298550. eCollection 2024.

本文引用的文献

1
Can reduction of uncertainties in cervix cancer brachytherapy potentially improve clinical outcome?降低宫颈癌近距离放疗中的不确定性是否有可能改善临床结果?
Radiother Oncol. 2016 Sep;120(3):390-396. doi: 10.1016/j.radonc.2016.06.008. Epub 2016 Jul 21.
2
Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix.子宫颈癌近距离放射治疗的处方、记录与报告
J ICRU. 2013 Apr;13(1-2):NP. doi: 10.1093/jicru/ndw027.
3
High-Dose-Rate Brachytherapy as Monotherapy for Intermediate- and High-Risk Prostate Cancer: Clinical Results for a Median 8-Year Follow-Up.
高剂量率近距离放射治疗作为中高危前列腺癌的单一疗法:中位8年随访的临床结果
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):675-82. doi: 10.1016/j.ijrobp.2015.05.044. Epub 2015 Jun 3.
4
A multicenter study to quantify systematic variations and associated uncertainties in source positioning with commonly used HDR afterloaders and ring applicators for the treatment of cervical carcinomas.一项多中心研究,旨在量化使用常用高剂量率后装治疗机和环形施源器进行宫颈癌治疗时源定位的系统变化及相关不确定性。
Med Phys. 2015 Aug;42(8):4472-83. doi: 10.1118/1.4923173.
5
A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.一项针对宫颈癌高剂量率近距离放射治疗的多中心“端到端”剂量测定审核。
Radiother Oncol. 2015 Feb;114(2):264-71. doi: 10.1016/j.radonc.2014.12.006. Epub 2015 Jan 9.
6
Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.临床近距离放射治疗不确定性综述:GEC-ESTRO和AAPM的分析指南
Radiother Oncol. 2014 Jan;110(1):199-212. doi: 10.1016/j.radonc.2013.11.002. Epub 2013 Nov 30.
7
Australasian brachytherapy audit: results of the 'end-to-end' dosimetry pilot study.澳大拉西亚近距离放射治疗审计:“端到端”剂量测定试点研究结果
J Med Imaging Radiat Oncol. 2013 Aug;57(4):490-8. doi: 10.1111/1754-9485.12042. Epub 2013 Feb 20.
8
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: an update.GEC/ESTRO 关于局部前列腺癌高剂量率后装近距离治疗的建议:更新版。
Radiother Oncol. 2013 Jun;107(3):325-32. doi: 10.1016/j.radonc.2013.05.002. Epub 2013 Jun 14.
9
Uncertainty analysis for 3D image-based cervix cancer brachytherapy by repetitive MR imaging: assessment of DVH-variations between two HDR fractions within one applicator insertion and their clinical relevance.基于 3D 图像的宫颈癌近距离放疗不确定性分析:重复性 MRI 成像评估同一施源器插入过程中两个 HDR 分次之间的剂量体积直方图(DVH)变化及其临床相关性。
Radiother Oncol. 2013 Apr;107(1):26-31. doi: 10.1016/j.radonc.2013.02.015. Epub 2013 Mar 27.
10
Dose calculation for photon-emitting brachytherapy sources with average energy higher than 50 keV: report of the AAPM and ESTRO.光子发射近距离放射治疗源的剂量计算:AAPM 和 ESTRO 报告。
Med Phys. 2012 May;39(5):2904-29. doi: 10.1118/1.3703892.